Company profile for Curadev Pharma Private Limited

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a small molecule drug discovery biotech with an exciting portfolio of research programs that have yielded patent protected drug candidates. Founded in 2010, Curadev has created a premier translational research organization known for prescient target selection and high quality, data-driven program execution. Our programs seek to ameliorate disease by translating cutting edge discoveries into new medicines. We have swiftl...
We are a small molecule drug discovery biotech with an exciting portfolio of research programs that have yielded patent protected drug candidates. Founded in 2010, Curadev has created a premier translational research organization known for prescient target selection and high quality, data-driven program execution. Our programs seek to ameliorate disease by translating cutting edge discoveries into new medicines. We have swiftly established our credentials by successfully creating and out-licensing our small molecule patents in immune-oncology.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
India
Address
Address
B 87, Sector 83, Noida, UP 201305
Telephone
Telephone
+91-120-408 1818/19
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/curadev-expands-strategic-collaboration-for-crd3874-si-through-msk-therapeutics-accelerator-program-302476573.html

PR NEWSWIRE
10 Jun 2025

https://www.prnewswire.com/news-releases/curadev-announces-first-treatment-cycle-completion-for-the-first-patient-dosed-in-a-phase-1ab-clinical-trial-of-its-allosteric-sting-agonist-crd3874-si-in-patients-with-advanced-cancer-at-memorial-sloan-kettering-cancer-center-in-302071911.html

PR NEWSWIRE
27 Feb 2024

https://www.prnewswire.com/news-releases/curadevs-differentiated-next-generation-sting-agonist-crd3874-si-302063167.html

PR NEWSWIRE
15 Feb 2024

https://www.prnewswire.com/news-releases/europaisches-patentamt-bestatigt-das-cyclodextrin-patent-von-curadev-fur-neue-stoffzusammensetzung-855849867.html

PRNEWSWIRE
09 Jun 2021

https://www.prnewswire.com/news-releases/european-patent-office-upholds-curadevs-cyclodextrin-patent-for-new-composition-of-matter-301308941.html

PRNEWSWIRE
09 Jun 2021

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty